MEDICINOVA, INC. Selling Expense
MEDICINOVA, INC. (MNOV) reported Selling Expense of $140.68 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2026-08-13
- MEDICINOVA, INC. selling expense for the quarter ending 2026-06-30 was $140.68K, a 20.91% increase year-over-year.
- MEDICINOVA, INC. selling expense for the quarter ending 2026-03-31 was $170.10K.
- MEDICINOVA, INC. selling expense for the quarter ending 2025-12-31 was $146.99K.
- MEDICINOVA, INC. selling expense for the quarter ending 2025-09-30 was $115.27K.
- MEDICINOVA, INC. selling expense for fiscal 2025 was $378.61K.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $140.68K 10-Q · filed 2026-08-13 | $310.78K 10-Q · filed 2026-08-13 | $457.77K derived: sum of 3 quarters · filed 2026-08-13 | $573.04K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $170.10K 10-Q · filed 2026-05-14 | $317.09K derived: sum of 2 quarters · filed 2026-05-14 | $432.36K derived: sum of 3 quarters · filed 2026-05-14 | $548.71K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $146.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $262.26K derived: sum of 2 quarters · filed 2026-03-10 | $378.61K derived: sum of 3 quarters · filed 2026-08-13 | $378.61K 10-K · filed 2026-03-10 |
| 2025-09-30 | $115.27K 10-Q · filed 2025-11-12 | $231.62K derived: sum of 2 quarters · filed 2026-08-13 | $231.62K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $116.35K 10-Q · filed 2026-08-13 | $116.35K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |